Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vicki G Davis

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Viruses|January 22, 2021
The Urinary Polyomavirus-Haufen Test: A Highly Predictive Non-Invasive Biomarker to Distinguish "Presumptive" from "Definitive" Polyomavirus Nephropathy: How to Use It-When to Use It-How Does It Compare to PCR Based Assays?Volker Nickeleit, Vicki G Davis, Bawana Thompson, et al.
Kidney International Reports|February 14, 2022
Increasing Incidence of Inadequate Kidney Biopsy Samples Over Time: A 16-Year Retrospective Analysis From a Large National Renal Biopsy LaboratoryCaleb J Nissen, Vanessa Moreno, Vicki G Davis, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|April 4, 2022
Classifying Polyomavirus Nephropathy: The "Banff" InitiativeVolker Nickeleit, H K Singh, Vicki G Davis, et al.
Translational Psychiatry|February 7, 2025
Methods to address functional unblinding of raters in CNS trialsSteven D Targum, William P Horan, Vicki G Davis, et al.
Viruses|February 27, 2026
A Mouse Model for "Definitive" Polyomavirus Nephropathy with End-Organ InjuryVolker Nickeleit, Dalton Butcher, Bawana Thompson, et al.
Schizophrenia Research|June 24, 2009
Can a nonequivalent choice of dosing regimen bias the results of flexible dose double blind trials? The CATIE schizophrenia trialRobert A Rosenheck, Vicki G Davis, Sonia M Davis, et al.
Kidney International|April 25, 2026
Clinical and Histologic Predictors of Non-Diabetic Kidney Disease in Patients with Diabetes MellitusTiffany N Caza, Vivek Charu, Dao-Fu Dai, et al.
Schizophrenia Research. Cognition|August 2, 2014
Virtual Reality Functional Capacity Assessment In Schizophrenia: Preliminary Data Regarding Feasibility and Correlations with Cognitive and Functional Capacity PerformanceStacy A Ruse, Philip D Harvey, Vicki G Davis, et al.
Schizophrenia Research|April 20, 2016
Validation of a Computerized test of Functional CapacityRichard S E Keefe, Vicki G Davis, Alexandra S Atkins, et al.
Journal of Affective Disorders|July 12, 2014
The Brief Assessment of Cognition In Affective Disorders (BAC-A):performance of patients with bipolar depression and healthy controlsRichard S E Keefe, Kolleen H Fox, Vicki G Davis, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Viruses|January 22, 2021
The Urinary Polyomavirus-Haufen Test: A Highly Predictive Non-Invasive Biomarker to Distinguish "Presumptive" from "Definitive" Polyomavirus Nephropathy: How to Use It-When to Use It-How Does It Compare to PCR Based Assays?Volker Nickeleit, Vicki G Davis, Bawana Thompson, et al.
Kidney International Reports|February 14, 2022
Increasing Incidence of Inadequate Kidney Biopsy Samples Over Time: A 16-Year Retrospective Analysis From a Large National Renal Biopsy LaboratoryCaleb J Nissen, Vanessa Moreno, Vicki G Davis, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|April 4, 2022
Classifying Polyomavirus Nephropathy: The "Banff" InitiativeVolker Nickeleit, H K Singh, Vicki G Davis, et al.
Translational Psychiatry|February 7, 2025
Methods to address functional unblinding of raters in CNS trialsSteven D Targum, William P Horan, Vicki G Davis, et al.
Viruses|February 27, 2026
A Mouse Model for "Definitive" Polyomavirus Nephropathy with End-Organ InjuryVolker Nickeleit, Dalton Butcher, Bawana Thompson, et al.
Schizophrenia Research|June 24, 2009
Can a nonequivalent choice of dosing regimen bias the results of flexible dose double blind trials? The CATIE schizophrenia trialRobert A Rosenheck, Vicki G Davis, Sonia M Davis, et al.
Kidney International|April 25, 2026
Clinical and Histologic Predictors of Non-Diabetic Kidney Disease in Patients with Diabetes MellitusTiffany N Caza, Vivek Charu, Dao-Fu Dai, et al.
Schizophrenia Research. Cognition|August 2, 2014
Virtual Reality Functional Capacity Assessment In Schizophrenia: Preliminary Data Regarding Feasibility and Correlations with Cognitive and Functional Capacity PerformanceStacy A Ruse, Philip D Harvey, Vicki G Davis, et al.
Schizophrenia Research|April 20, 2016
Validation of a Computerized test of Functional CapacityRichard S E Keefe, Vicki G Davis, Alexandra S Atkins, et al.
Journal of Affective Disorders|July 12, 2014
The Brief Assessment of Cognition In Affective Disorders (BAC-A):performance of patients with bipolar depression and healthy controlsRichard S E Keefe, Kolleen H Fox, Vicki G Davis, et al.
Pageof 3